Dambkowski Carl sold ORKA
June 12, 2026 · Form 4 insider transaction
Dambkowski Carl sold 12,583 shares of Oruka Therapeutics, Inc. at $70.11 per share, a transaction worth $882.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
12,583
Price
$70.11
Total value
$882.2K
InsiderDambkowski Carl
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 12, 2026
Filing dateJune 12, 2026
Shares owned after38,743
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 19, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.50, inclusive.